2022 annual financial data
PharmaCyte Biotech 2022 Financial results
Direct answer
Revenue was 0 USD.
Operating income was -4,392,000 USD and net income was -4,239,161 USD.
Operating cash flow was -4,117,319 USD.
Get free PharmaCyte Biotech email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -4,392,000 USD
- Net income
- -4,239,161 USD
- Operating cash flow
- -4,117,319 USD
Explore related company data
View all 2022 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Net marginView Operating cash flow marginView all PharmaCyte Biotech financial years